Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Werewolf Therapeutics Inc is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. Werewolf Therapeutics Inc is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer.
– Data from expansion arms in Phase 1/1b clinical trial evaluating WTX-124 as monotherapy expected in first half of 2025 to guide regulatory engagement on potential registrational pathways –...
WATERTOWN, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development...
- Interim phase 1 clinical trial update reveals the clinical potential of the tumor-activated IL-12 prodrug WTX-330, with favorable tolerability profile and encouraging efficacy signals...
– Interim data from ongoing Phase 1 clinical trial of WTX-330, further characterizing tolerability and activity profile, to be presented at SITC Annual Meeting – – Monotherapy and combination...
WATERTOWN, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.07 | -4.92957746479 | 1.42 | 1.42 | 1.31 | 384701 | 1.36582111 | CS |
| 4 | -0.1487 | -9.92193234136 | 1.4987 | 1.72 | 1.31 | 329572 | 1.48562737 | CS |
| 12 | -1.76 | -56.5916398714 | 3.11 | 3.2644 | 1.31 | 454635 | 1.98084988 | CS |
| 26 | -1.6 | -54.2372881356 | 2.95 | 4.15 | 1.31 | 473975 | 2.51731127 | CS |
| 52 | -3.48 | -72.049689441 | 4.83 | 8.1939 | 1.31 | 376211 | 3.21379809 | CS |
| 156 | -7.53 | -84.7972972973 | 8.88 | 9.47 | 1.31 | 295127 | 3.46648027 | CS |
| 260 | -16.86 | -92.586490939 | 18.21 | 23.99 | 1.31 | 260629 | 4.45382993 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
